Stockscreener 앱 받기
1.14
0.87%
-0.01
전일 마감가:
$1.15
열려 있는:
$1.12
하루 거래량:
63,653
Relative Volume:
0.27
시가총액:
$13.80M
수익:
-
순이익/손실:
-
주가수익비율:
-
EPS:
-
순현금흐름:
-
1주 성능:
+5.56%
1개월 성능:
+10.68%
6개월 성능:
+47.10%
1년 성능:
-90.74%
1일 변동 폭
$1.11
$1.17
1주일 범위
$1.05
$1.18
52주 변동 폭
$0.375
$11.71
AEON Biopharma Inc. Stock (AEON) Company Profile
명칭
AEON Biopharma Inc.
전화
(949) 354-6499
주소
5 Park Plaza, Suite 1750, Irvine
AEON을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
AEON
AEON Biopharma Inc.
|
1.14 | 13.92M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
441.36 | 111.36B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
733.04 | 77.98B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
800.01 | 50.33B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
359.27 | 47.46B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
338.19 | 37.43B | 4.98B | 69.59M | 525.67M | 0.5197 |
AEON Biopharma Inc. Stock (AEON) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2023-08-18 | 개시 | H.C. Wainwright | Buy |
AEON Biopharma Inc. 주식(AEON)의 최신 뉴스
Midday Stock Roundup: loanDepot Jumps on Trump’s Proposed Mortgage Plan - Orange County Business Journal
Rate Cut: Whats the MACD signal for AEON Biopharma Inc2025 Macro Impact & AI Powered Market Entry Ideas - baoquankhu1.vn
Market Wrap: Can AEON Biopharma Inc keep up with sector leadersJuly 2025 Rallies & Risk Controlled Swing Alerts - baoquankhu1.vn
AEON Biopharma (AEON) Price Target Decreased by 14.75% to 5.30 - Nasdaq
Midday Stock Roundup: Staar Down 4% on Board Changes - Orange County Business Journal
AEON Biopharma Releases Updated Investor Presentation Under Reg FD - TipRanks
AEON Biopharma, Inc. Unveils Biosimilar Strategy for ABP-450 - TradingView — Track All Markets
AIM ImmunoTech, PepGen, Aeon, Tiziana, Moleculin: 5 Biotech Stocks That Led Retail Message Growth Last Week - MSN
Midday Stock Roundup: loanDepot Rises on Trump Move - Orange County Business Journal
AEON Biopharma (NASDAQ:AEON) & Synaptogenix (NASDAQ:TAOX) Head to Head Analysis - Defense World
Why AEON Biopharma Inc. Class stock stays on buy listsJuly 2025 Trends & Low Drawdown Investment Ideas - Улправда
Will AEON Biopharma Inc. Class stock outperform foreign stocksWeekly Stock Report & Low Drawdown Trading Strategies - Улправда
What technical signals suggest for AEON Biopharma Inc. stockGDP Growth & Momentum Based Trading Ideas - Улправда
What dividend safety rating applies to AEON Biopharma Inc. Class stockWeekly Earnings Recap & Low Risk Entry Point Guides - Улправда
AEON Biopharma, Inc. Class A Common Stock (NY: AEON - FinancialContent
What insider trading reveals about AEON Biopharma Inc. stockHigh Yield Income Stocks & Ride the Wave of Market-Beating Growth - Улправда
2026 world cup star players explained: How AEON Biopharma Inc. Class stock compares with tech leaders2026 world cup usa national team third place match key players pressing system expert forecast preview - Улправда
2026 world cup match report guide: How AEON Biopharma Inc. stock benefits from global expansion2026 world cup usa national team semifinals defensive leaders pressing system winner prediction preview - Улправда
Can AEON Biopharma Inc. Class stock stage a strong rebound this quarter2026 world cup usa national team qualification playmakers high defensive line odds analysis preview - Улправда
Midday Stock Roundup: Rivian Down on Production Totals - Orange County Business Journal
AEON Biopharma, Inc. (AEON) Stock Forecast & Price Prediction 2025–2030 - CoinCodex
AEON Biopharma (NASDAQ:AEON) Trading Up 5.9% – Time to Buy? - Defense World
AEON Biopharma (AEON) seeks shareholder approval for PIPE, note exchange and equity plan - Stock Titan
Will AEON Biopharma Inc. stock split attract more investorsMarket Sentiment Indicators & Calculate Profit Targets With AI Accuracy - bollywoodhelpline.com
Midday Stock Roundup: Shimmick Corp. climbs 14% - Orange County Business Journal
Aug EndMonth: How AEON Biopharma Inc stock benefits from global expansionWeekly Profit Recap & Risk Managed Investment Strategies - moha.gov.vn
Insider Buy: Can AEON Biopharma Inc Class stock stage a strong rebound this quarterJuly 2025 Rallies & Low Drawdown Trading Techniques - moha.gov.vn
Is AEON Biopharma Inc. Class stock bottoming after sell offBond Market & Community Verified Trade Signals - Улправда
Investor Mood: Can AEON Biopharma Inc. Class stock stage a strong rebound this quarter - Улправда
AEON Biopharma Reports Inducement Grants Under NYSE American LLC Company Guide Section 711 - The Manila Times
How AEON Biopharma Inc. stock benefits from global expansionEarnings Recap Summary & Weekly High Potential Stock Alerts - Улправда
AEONAeon Biopharma Latest Stock News & Market Updates - Stock Titan
Will AEON Biopharma Inc. Class stock benefit from infrastructure billWeekly Trading Summary & Reliable Breakout Stock Forecasts - Улправда
Biopharmaceutical company offers new hires stock units over four years - Stock Titan
[PRE 14A] AEON Biopharma, Inc. Preliminary Proxy Statement - Stock Titan
Midday Stock Roundup: Rivian Stock Continues to Climb - Orange County Business Journal
Is AEON Biopharma Inc. Class stock undervalued historicallyEarnings Overview Summary & Pattern Based Trade Signal System - DonanımHaber
Will AEON Biopharma Inc. Class stock sustain dividend payoutsJuly 2025 Analyst Calls & Long Hold Capital Preservation Plans - DonanımHaber
Will AEON Biopharma Inc. stock recover faster than marketMarket Sentiment Review & Smart Allocation Stock Reports - DonanımHaber
AEON Biopharma Earnings Notes - Trefis
AEON Biopharma Announces Execution of Exchange Agreement with Daewoong - The Manila Times
AEON Biopharma IncExchange to Eliminate Ov - 富途牛牛
AEON Biopharma announces execution of exchange agreement with Daewoong Pharmaceutical - MSN
Aeon Biopharma announces execution of exchange agreement with Daewoong - marketscreener.com
AEON Biopharma Announces Exchange Agreement with Daewoong - TipRanks
AEON Biopharma Inc. (AEON) 재무 분석
AEON Biopharma Inc. (AEON)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.
매출
순이익
현금흐름
주당 순 이익
4.73%
0.92%
자본화:
|
볼륨(24시간):